Wed. 6 Mar 2024, 3:01am ET
Benzinga
News
- IPH45 abstract selected for oral presentation at AACR Annual Meeting 2024
- Preclinical data support further development of IPH45, a differentiated topoisomerase I inhibitor ADC targeting Nectin-4, which is progressing towards the clinic